Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.10B | 1.14B | 1.19B | 1.59B | 1.21B | 966.67M |
Gross Profit | 367.14M | 418.94M | 387.46M | 377.37M | 441.71M | 378.88M |
EBITDA | 430.96M | 507.59M | 472.14M | 470.33M | 519.56M | 456.88M |
Net Income | 161.24M | 62.39M | 54.28M | 334.83M | 401.38M | 341.12M |
Balance Sheet | ||||||
Total Assets | 1.31B | 1.29B | 1.32B | 1.37B | 1.48B | 1.36B |
Cash, Cash Equivalents and Short-Term Investments | 36.58M | 58.32M | 58.62M | 64.78M | 17.06M | 17.15M |
Total Debt | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M | 399.67M |
Total Liabilities | 476.02M | 458.64M | 460.59M | 468.27M | 508.00M | 441.35M |
Stockholders Equity | 504.99M | 518.70M | 522.51M | 903.71M | 972.70M | 915.14M |
Cash Flow | ||||||
Free Cash Flow | 268.42M | 436.03M | 405.18M | 409.62M | 327.27M | 336.43M |
Operating Cash Flow | 313.39M | 485.00M | 452.00M | 463.74M | 408.44M | 373.40M |
Investing Cash Flow | -19.36M | -88.97M | -75.94M | -12.00M | -64.30M | 2.03M |
Financing Cash Flow | -323.46M | -396.33M | -382.23M | -404.01M | -344.24M | -378.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $772.78M | 14.68 | 10.28% | 8.60% | -7.24% | -7.30% | |
63 Neutral | $508.43M | 6.67 | 9.85% | 3.25% | 1.31% | 796.76% | |
51 Neutral | $543.84M | ― | -6.51% | ― | 2.60% | -1506.69% | |
50 Neutral | $1.64B | ― | -10.43% | 9.82% | -1.56% | -259.58% | |
44 Neutral | AU$1.54B | -7.28 | -22.76% | 4.37% | -3.13% | -36.41% | |
42 Neutral | $1.28B | ― | -8638.28% | ― | -3.33% | 44.37% | |
40 Underperform | $596.05M | ― | -14.11% | 11.30% | 0.20% | -292.54% |
Westlake Chemical Partners LP reported a net income of $14.6 million for the second quarter of 2025, consistent with the previous year’s results, despite a significant decrease in cash flows from operating activities due to higher maintenance capital expenditures from the Petro 1 turnaround. The company announced its 44th consecutive quarterly distribution and expects improvement in distributable cash flow and coverage ratio in the second half of 2025, following the completion of the Petro 1 turnaround.
The most recent analyst rating on (WLKP) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on Westlake Chemical PRN stock, see the WLKP Stock Forecast page.